EFFECT OF DANAZOL ON SERUM GONADOTROPHINS AND STEROID HORMONE CONCENTRATIONS IN WOMEN WITH MENORRHAGIA
Authors:
- 1 April 1980
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 87 (4) , 330-336
Abstract
In 13 ovulatory women with objective evidence of menorrhagia (menstrual blood loss greater than 80 ml), danazol 400 mg given daily for 12 weeks suppressed ovulation as shown by absence of gonadotrophin peaks, low serum progesterone levels and flat basal body temperature recordings. Serum concentrations of luteinising hormone and follicle stimulating hormone were within the range found during the normal menstrual cycle but oestradiol concentrations tended to fall, reaching levels less than 100 pmol/l in some patients. Danazol treatment had no effect on levels of androstenedione or dehydroepiandrosterone and its sulphate. The presence or absence of cyclical bleeding on treatment, and the measured blood loss was unrelated to circulating oestradiol levels.Keywords
This publication has 13 references indexed in Scilit:
- Effect of danazol on estradiol-17β and progesterone secretion by porcine ovarian cells in vitroAmerican Journal of Obstetrics and Gynecology, 1979
- Effects of Danazol on Pituitary Gonadotrophins in Post‐Menopausal WomenAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1978
- MECHANISM OF ANTIPROGESTATIONAL ACTION OF SYNTHETIC STEROIDSEuropean Journal of Endocrinology, 1978
- Increased utero-ovarian androstenedione production before parturition in sheepReproduction, 1976
- Ovarian and Adrenal Contribution to Peripheral Androgens During the Menstrual CycleThe Journal of Clinical Endocrinology & Metabolism, 1974
- SIGNIFICANT FALL IN PROGESTERONE AND RISE IN $OElig;STRADIOL LEVELS IN HUMAN PERIPHERAL PLASMA BEFORE ONSET OF LABOURThe Lancet, 1974
- Pituitary Gonadotropins and Ovarian Function in Adolescent Dysfunctional Uterine BleedingThe Journal of Clinical Endocrinology & Metabolism, 1973
- Pituitary and Testicular Function Studies. I. Experience with a New Gonadal Inhibitor, 17α-Pregn-4-en-20-yno-(2,3-d) isoxazol-17-ol (Danazol)1The Journal of Clinical Endocrinology & Metabolism, 1971
- Clinical Studies with an Antigonadotropin-DanazolFertility and Sterility, 1971
- Determination of Menstrual Blood LossScandinavian Journal of Clinical and Laboratory Investigation, 1964